Full Press Release Details
Press Releases
Video Library
Careers
EAU 2025 PIVOT-006 TRIAL IN PROGRESS
by
admin
Apr 3, 2025
congress-hub-presentations
CGON Neutral Sentiment
EAU 2025 PIVOT-006 TRIAL IN PROGRESS
Key Takeaway: The EAU 2025 PIVOT-006 trial is currently underway, as announced in a recent press release. Details regarding the trial's objectives and methodology have not been disclosed. The announcement was made on April 3, 2025, indicating ongoing research efforts in this area.
Price reaction · baseline $19.25 (2025-04-03T17:24:00.000Z) · hit during market hours · 3 other CGON headline(s) in the window, move may be shared
day 0 close · peak
-2.6%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+139%
120-day peak, hindsight
Typical move
6.3%
average across 5 past catalysts
Cash runway
~66 mo
Minimal dilution risk
Lead asset
CG0070
Phase 2 · Non Muscle Invasive Bladder Cancer